Hypertension Trial, Recruiting NCT07461415 Sponsor: Weill Medical College of Cornell University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07461415
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who arrive at the emergency department with a high blood pressure reading (top number above 180 and/or bottom number above 110), confirmed by a second similar reading taken at least 30 minutes later
  • People who may have already received some treatment for high blood pressure during their emergency department visit, as long as there are no signs of damage to major organs such as the brain, heart, or kidneys, and no swelling behind the eyes
  • People who are well enough to be sent home from the emergency department, or who are admitted only because of high blood pressure with no other complications
  • People referred from a clinic to the emergency department with blood pressure readings in the range described above
  • People who are able to give their agreement to take part in the study — the trial is designed to be accessible to people of all reading and writing abilities
  • People who are able to receive phone calls and in-person visits — a smartphone is not required, as the trial works with standard phones

Who may not be able to join:

  • People who are pregnant
  • People who have a terminal illness
  • People who need to be admitted to hospital because of serious complications beyond high blood pressure alone

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Junaid Razzak, MD PhD FACEP, Weill Medical College of Cornell University

Phone: +1 4437229239

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 March 2026
Est. completion
1 August 2029

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Rate of Major Adverse Cardiac Events (MACE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov